Biology Atlas

Map / Open register

question · intermediate · partly written

Why did revusiran, an siRNA against transthyretin, have more on-treatment deaths than placebo?

ENDEAVOUR was stopped for a mortality imbalance, and the authors state that no clear causative mechanism was identified.

The question in brief

Two drugs against the same protein had opposite outcomes, and the cause of the harm is unknown. 1

Reported, not yet replicated

Observation

On-treatment deaths were 18 of 140 on revusiran against 2 of 66 on placebo, and the study stopped early (abstract). 1

Reported, not yet replicated

Hypotheses

Chemistry, dose or population

Differences from patisiran in chemistry, dosing schedule and an advanced-heart-failure population may each contribute. 1

Predicts. Excess deaths should not appear in healthier populations.

Would falsify. Same excess with a different chemistry in the same population.

Our inference

What is missing

Mechanism

No source opened here identifies the cause. 1

Our inference

What is known

The excess is on record in the trial abstract, and the authors found no clear mechanism. 1

Reported, not yet replicated

What is not

The cause, and whether it would recur in a healthier population. 1

Reported, not yet replicated

What would settle it

Full-text analysis of causes of death and a trial in a different population, which no opened source reports. 1

Our inference

Still open here

Not yet written: Who works on it.

Sources

  1. Judge DP, et al.. Phase 3 Multicenter Study of Revusiran in Patients with Hereditary Transthyretin-Mediated (hATTR) Amyloidosis with Cardiomyopathy (ENDEAVOUR). Cardiovasc Drugs Ther (2020). paper; opened 2026-11-17 all records citing this
History of this record (1)

This record has been changed 1 time, on the dates below. The note kept against each change is written for the people who maintain the atlas, in their own shorthand, so it is not shown here; it is in the record itself.

Kind
big-open
Register
open-question
Triage
needs-research
Status
partly written
Last updated
2026-11-17
Record
content/questions/why-did-revusiran-increase-deaths.json